metabolite_data: Metabolomics data

In molnet-org/molnet: Predicting Differential Drug Response using Multi-Omics Networks

Description

Metabolomics analysis of breast cancer patients data sampled randomly to generate distributions similar to those reported e.g. in (Terunuma et al., 2014). The data is stratified by estrogen receptor (ER) expression status (group1 = ER+, group2 = ER-). Each group is given as a sub-list containing 'data' (raw data, metabolites in columns and samples in rows) and 'identifiers' (one column per identifier, rows in the same order as the metabolites order in 'data').

Usage

metabolite_data

Format

group1

ER+ data

data

raw data, metabolites in columns and samples in rows

identifiers

one column per identifier, rows in the same order as the metabolite order in 'data', identifiers: biochemical name, METABOLON ID, Pubchem ID

group2

ER- data

data

see above

identifiers

see above

Source

Terunuma, Atsushi et al. “MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.” The Journal of clinical investigation vol. 124,1 (2014): 398-412. doi:10.1172/JCI71180

https://www.metabolon.com

Pubchem IDs: https://pubchem.ncbi.nlm.nih.gov

MetaboAnalyst: https://www.metaboanalyst.ca/faces/upload/ConvertView.xhtml

molnet-org/molnet documentation built on Dec. 21, 2021, 8:59 p.m.